Anti-PD1 treatment in metastatic uveal melanoma in the Netherlands

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies

(2016) Alain P. Algazi et al.   CANCER

The use of pembrolizumab for the treatment of metastatic uveal melanoma

(2016) Lisa A. Kottschade et al.   MELANOMA RESEARCH

Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases

(2015) Marybeth S. Hughes et al.   ANNALS OF SURGICAL ONCOLOGY

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

(2015) Lisa Zimmer et al.   PLoS One

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma

(2014) Richard D. Carvajal et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O)

(2013) Sander Kelderman et al.   ACTA ONCOLOGICA

Efficacy and safety of ipilimumab in patients with pre-treated, uveal melanoma

(2013) M. Maio et al.   ANNALS OF ONCOLOGY

Radiofrequency ablation in metastatic melanoma

(2013) Arridh Shashank et al.   JOURNAL OF SURGICAL ONCOLOGY

Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe

(2011) S. Mallone et al.   EUROPEAN JOURNAL OF CANCER

Stereotactic body radiation therapy for melanoma and renal cell carcinoma: impact of single fraction equivalent dose on local control

(2011) Michelle A Stinauer et al.   Radiation Oncology

Transarterial chemoembolization of liver metastases in patients with uveal melanoma

(2009) P.E. Huppert et al.   EUROPEAN JOURNAL OF RADIOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER